Overview
ABEO market data
Price History
ABEO price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ABEO. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Abeona Therapeutics Activates Cincinnati Children’s As Seventh Qualified Treatment Center For Administration Of ZEVASKYN To Treat Wounds In Patients With Recessive Dystrophic Epidermolysis BullosaBenzinga · Jul 21, 2026, 11:37 AM
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globenewswire Inc · Jul 1, 2026, 12:15 PM
8-K filing — ABEONA THERAPEUTICS INC. (ABEO)SEC EDGAR · Jun 12, 2026, 11:30 AM
Abeona Therapeutics Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 13, 2026, 1:51 PM
Abeona Reports Strong Q1 Revenue, Expands Treatment Center NetworkBenzinga · May 13, 2026, 1:31 PM
Abeona Therapeutics Q1 EPS $(0.30) Beats $(0.35) Estimate, Sales $8.720M Beat $4.572M EstimateBenzinga · May 13, 2026, 11:35 AM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM
Abeona Therapeutics Activates Children's Hospital Of Philadelphia As Sixth Qualified Treatment Center To Treat ZEVASKYN Gene-Modified Cellular SheetsBenzinga · May 11, 2026, 12:34 PM